Page last updated: 2024-11-13
lithium cobalt oxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
lithium cobalt oxide: primary cathode material of rechargeable lithium batteries [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 23670860 |
MeSH ID | M0473576 |
Synonyms (18)
Synonym |
---|
cobalt lithium dioxide |
12190-79-3 |
ec 235-362-0 |
lithium colbaltite |
lithium cobalt iii oxide |
einecs 235-362-0 |
lithium cobalt(iii) oxide |
lithiumcobalt(iii)oxide |
mfcd00049786 |
lithium cobalt oxide |
lithium cobalt dioxide |
cobalt lithium oxide |
Q415891 |
lithium nickel cobalt oxide powder |
manganese sulfide (mns2) sputtering targets |
H11983 |
lithium;oxido(oxo)cobalt |
lithium cobalt oxide nanopowder |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
---|---|---|
" In vitro bioelution in simulated gastric fluid was the most precise predictor of the difference in the oral RDT lowest observed adverse effect levels of 2 compounds representing the highly and poorly bioaccessible subset of substances." | ( Bioelution, Bioavailability, and Toxicity of Cobalt Compounds Correlate. Burzlaff, A; Danzeisen, R; Dourson, M; Verberckmoes, S; Viegas, V; Williams, DL, 2020) | 0.56 |
Bioavailability
Excerpt | Reference | Relevance |
---|---|---|
" We were able to show a good correlation between high in vitro bioaccessibility with high in vivo bioavailability and subsequent high in vivo toxicity; consequently, low in vitro bioaccessibility correlated well with low in vivo bioavailability and low in vivo toxicity." | ( Bioelution, Bioavailability, and Toxicity of Cobalt Compounds Correlate. Burzlaff, A; Danzeisen, R; Dourson, M; Verberckmoes, S; Viegas, V; Williams, DL, 2020) | 0.56 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (38)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (10.53) | 29.6817 |
2010's | 24 (63.16) | 24.3611 |
2020's | 10 (26.32) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 63.69
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (63.69) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 38 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |